TY - JOUR JO - Central European Journal of Immunology SN - 1426-3912 VL - 43 IS - 1 PY - 2018 ID - Mozaffari2018 TI - Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: a meta-analysis study AB - Interleukin-6 (IL-6) is a cytokine that contributes to the pathogenesis of oral lichen planus (OLP). The aim of this meta-analysis study is the evaluation of IL-6 levels in the serum and saliva of patients with OLP compared with healthy controls. We searched the studies in 5 databases: PubMed/Medline, Scopus, ScienceDirect, Web of Science, and Cochrane Library, from 1983 to Oct 31, 2016. Eleven studies were analysed for the meta-analysis study. The reviewers independently evaluated the quality of each included study using the Newcastle-Ottawa Quality Assessment Scale (NOS). A random-effects meta-analysis, using Comprehensive Meta-Analysis software version 2.0, was used to reflect the variation in studies. Heterogeneity between estimates was evaluated by the Q and I2 statistics and for the Q statistic; heterogeneity was considered for p < 0.1. Eleven studies included 529 OLP patients and 333 healthy controls. The review identified two different biomaterials used for IL-6 assays: saliva and serum. The mean quality score of eleven studies was 7 (high quality). Estimates pooled from 6 studies showed significant high saliva IL-6 levels in OLP patients compared with healthy controls (the standardised difference in means (SDM) = 4.534, 95% CI = 1.915-7.153, p = 0.001). Also, estimates pooled from 7 studies showed significantly high serum IL-6 levels in OLP patients compared with healthy controls (SDM = 1.482, 95% CI = 0.524-2.439, p = 0.002). The higher levels of IL-6 in saliva compared with serum suggest that measurement of this marker in saliva may be more useful than serum for diagnostic and therapeutic aims. AU - Mozaffari, Hamid Reza AU - Sharifi, Roohollah AU - Sadeghi, Masoud SP - 103 EP - 108 DA - 2018 DO - 10.5114/ceji.2018.74880 UR - http://dx.doi.org/10.5114/ceji.2018.74880 ER -